
Abbott’s Latest‑Generation FreeStyle Libre 3 Plus Glucose Monitoring Technology Launches in Saudi Arabia
Rashad Iskandrni
• Abbott continues to
transform diabetes care with its leading Libre systems
•
FreeStyle Libre 3 Plus* system is designed to make diabetes management
easier with real-time insights into glucose monitoring and extended 15-day wear
time, while maintaining a very small, discreet, and easy-to-apply design
|
|
|
|
The launch comes at a critical time as Saudi
Arabia continues to face one of the world’s highest diabetes prevalence rates,
with more than 5 million adults – nearly 1 in 4 – living with the condition[1]. Libre CGM systems help people living with
diabetes better understand how different foods, exercise and medications[2] impact their glucose levels in real time, enabling
them to make more informed decisions[3] on how they can manage their diabetes on
their own terms.
Designed to make glucose monitoring simpler
and more user-friendly[4], FreeStyle Libre 3 Plus* empowers individuals
to take an active role in living with their condition, increasing confidence[5] and driving better health outcomes[6],[7],[8].
The FreeStyle Libre 3 Plus sensor is Abbott’s
smallest sensor to date‡, developed with user’s everyday needs in mind. The
sensor is discreet, easy‑to‑apply, and offers an extended wear of up to 15 days — requiring only six sensors every three months — while providing outstanding accuracy[9] with real-time glucose readings sent
directly to FreeStyle Libre 3 users’ smartphone app#.
The system is approved for all people with
diabetes aged 2 and older, including pregnant women, reinforcing Abbott’s
commitment to helping people access the care they need and live healthier,
fuller lives.
"As the global leader in CGM, Abbott
continues to advance the standard of diabetes care and make it easier for
people to manage their condition," said Mohammad Househ, general manager of
Abbott’s diabetes care business in Saudi Arabia, Bahrain, the Middle East and
Northern Africa. "We are proud to introduce in Saudi Arabia FreeStyle
Libre 3 Plus*, our most compact and user-friendly sensor yet, offering
transformative benefits to help people living with diabetes take actions that
can add up to big changes over time."
To learn more about Abbott’s FreeStyle Libre
3 Plus* sensor, visit FreeStyle.abbott/sa
Figure
1
ABBOTT’S LATEST GENERATION FREESTYLE LIBRE 3 PLUS LAUNCHES IN SAUDI ARABIA
-End-
About
FreeStyle Libre:
Abbott continues to pioneer ground-breaking technology to support people
living with diabetes. The company revolutionized diabetes care more than 10
years ago with its world-leading FreeStyle Libre continuous glucose monitoring
portfolio, which today is used by more than 8 million people across over 60
countries. People use Libre technology to see their glucose numbers in
real-time, providing insights into how food, activity, or insulin impacts their
glucose[10]
to help them make progress on their health goals. There is full or partial
reimbursement for Libre systems in more than 40 countries.[11]
About Abbott:
Abbott is
a global healthcare leader that helps people live more fully at all stages of
life. Our portfolio of life-changing technologies spans the spectrum of
healthcare, with leading businesses and products in diagnostics, medical
devices, nutritionals and branded generic medicines. Our 122,000 colleagues
serve people in more than 160 countries.
Connect
with us at www.arabia.abbott and
on LinkedIn, Facebook, Instagram, X, and YouTube.
|
Abbott
Media: Rawan Abdelaziz, rawan.abdelaziz@abbott.com,
+971 50 926 8157
|
###
DISCLAIMERS:
*
The FreeStyle Libre 3 Flash Glucose Monitoring System (FreeStyle Libre 3 Reader
or Freestyle Libre 3 app used with FreeStyle Libre 3 Plus Sensor) is indicated
for measuring interstitial fluid glucose levels continuously in people aged 2
years and older with diabetes mellitus. Always read and follow the
label/insert.
# The FreeStyle Libre 3 app is only
compatible with certain mobile devices and operating systems. Please check the
website for more information about device compatibility before using the app.
Use of FreeStyle Libre 3 app requires registration with LibreView.
‡ In comparison with other
FreeStyle Libre system sensors.
[1] Diabetes in Saudi
Arabia (2024), International Diabetes Federation
[2] Continuous
Glucose Monitoring - NIDDK.” National Institute of Diabetes and Digestive and
Kidney Diseases. Accessed June 23, 2025.
https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes/continuous-glucose-monitoring.
[3] Fokkert,
M. BMJ Open Diabetes Research & Care (2019).
https://doi.org/10.1136/bmjdrc-2019-000809.
[4] Haak, T. Diabetes Therapy (2017):
https://doi.org/10.1007/s13300-016-0223-6
[5] Fokkert
M. BMJ Open Diab Res Care (2019): http://dx.doi.org/10.1136/bmjdrc-2019-000809
[6] Bolinder,
J. Lancet (2016): https://doi.org/10.1016/S0140-6736(16)31535-5
[7] Yaron,
M. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166
[8] Haak,
T. Diabetes Therapy (2017): https://doi.org/10.1007/s13300-016-0223-6
[9] Accuracy
of a 15-day Factory-Calibrated Continuous Glucose Monitoring System With
Improved Sensor Design. Journal of Diabetes Science and Technology (2025) DOI:
10.1177/19322968251329364
journals.sagepub.com/home/dst
[10] Continuous
Glucose Monitoring - NIDDK.” National Institute of Diabetes and Digestive and
Kidney Diseases. Accessed June 23, 2025.
https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes/continuous-glucose-monitoring.
[11] Data
on file. Abbott Diabetes Care, Inc.

.jpeg)






